Compared with T2DM patients initiated on insulin glargine in Turkey, insulin detemir was associated with a similar level of glycaemic control, but a lower risk of hypoglycaemia and greater odds of weight loss, after correction for a number of known confounders. This evidence concerns the gene INS and Hypoglycemia.